Nasus Pharma Announces Data Demonstrating In Vitro Efficacy of Taffix® Intranasal Antiviral Spray Against SARS-CoV-2 British and South African Variants
TEL AVIV, Israel, April 21, 2021 /PRNewswire/ — Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address

